Julie Butters
North Terrace
Adelaide, SA, Australia
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial.
Journal: Nature medicine
Published: April 17, 2026
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
Journal: The New England journal of medicine
Published: May 08, 2025
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis.
Journal: European journal of preventive cardiology
Published: February 13, 2025
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?
Journal: Expert opinion on pharmacotherapy
Published: September 26, 2024
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.
Journal: Cardiovascular research
Published: April 09, 2024
Pop-up screening nested within routine community activities unmasks an addressed cardiovascular risk: A pilot study (Gippsland Healthy Heart Study).
Journal: The Australian journal of rural health
Published: March 21, 2023
Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes.
Journal: JACC. Cardiovascular imaging
Published: May 03, 2022
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
Journal: JACC. Cardiovascular imaging
Published: January 13, 2022
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
Journal: Cardiovascular drugs and therapy
Published: August 13, 2021
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region.
Journal: JACC. Asia
Published: May 10, 2021
Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.
Journal: Cardiovascular diagnosis and therapy
Published: March 12, 2021
Last Updated: 09/26/2026